Stephen C. Shiboski, PhD

University of Wyoming, BS, 1975, Aquatic Biology
Oregon State University, MS, 1983, Statistics
University of California, Berkeley, PhD, 1991, Biostatistics

• 9/83 - 8/85
  Research Scientist, Office of Science & Research, New Jersey Dept. Environmental Protection
• 10/85 - 8/86
  Statistician, International Agency for research on Cancer (WHO), Lyon, France
• 10/86 - 8/87
  Research Scientist, New Jersey Department of Health
• 12/87 - 2/89
  Research Assistant, San Francisco Men's Health Study
• 2/89 - 7/91
  Senior Statistician, Dept. Epidemiology & Biostatistics, University of California, San Francisco
• 7/91 - 6/07
  Assistant & Associate Prof., Dept. Epidemiology & Biostatistics, Univ. of California, San Francisco
• 7/07 - present
  Professor, Dept. Epidemiology & Biostatistics, University of California, San Francisco

• 1990
  Krueger Memorial fellowship from the School of Public Health, University of California, Berkeley
• 1991
  Evelyn Fix Memorial Medal from the Department of Statistics, University of California, Berkeley
• 1992
  New Investigator award from the Center for AIDS Research, University of California, San Francisco
• 1994
  Scholar award from the American Foundation for AIDS Research

• Jewell NP, van der Laan MJ, Shiboski S. Choice of Monitoring Mechanism for Optimal Nonparametric Functional Estimation for Binary Data. The International Journal of Biostatistics 2:Article 7, 2006.
• Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, et al; MIRA Team. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 370:251-61, 2007.
• Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, Shaber R, Shiboski S. Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology. Obstet Gynecol. 2008;112:1335-42.
• Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Cohen CR. Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis. 2009;36:564-9. PMID: 19543144
• Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol. 2009;27:4162-8. PMID: 19636009
• Chen H, Shiboski SC, Golden JA, Gould MK, Hays SR, Hoopes CW, De Marco T. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180:468-74. PMID: 19520906
• Rosenblum M, Jewel NP, van der Laan, MJ, Shiboski S, van der Straten A, Padian N. Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials. J Royal Stat Soc, Ser A, (Statistics in Society), 2009; Volume 172: 443-465.
• Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Foster-Rosales A, Cohen CR. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis. 2010;37:745-50. PMID: 20644497
• Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010;116:1373-80. PMID: 21099605
• Shiboski S, Rosenblum M, Jewell NP. The impact of secondary condom interventions on the interpretation of results from HIV prevention trials. Stat. Comm. Infect. Dis. 2010;2: Iss. 1, Article 2.
• Cohen CR, Brown J, Moscicki AB, Bukusi EA, Paull JR, Price CF, Shiboski S. A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days. PLoS One. 2011;6(1):e16258. PMID: 21311578
• Daud II, Scott ME, Ma Y, Shiboski S, Farhat S, Moscicki AB. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer. 2011;128:879-86. PMID: 20473890
• Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Jun 17. PMID: 21681446
• de Bruyn G, Shiboski S, van der Straten A, Blanchard K, Chipato T, Ramjee G, Montgomery E, Padian N; MIRA Team. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect. 2011;87:301-5. PMID: 21447515